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Abstract: 
Objectives: to determine the common causes of liver cirrhosis, identify the 
common complications, and to find the possible preventive measures of the 
disease at Elobeid Hospital; West Sudan. 
Patients and method: This is a retrospective hospital based study. It was 
carried out in Elobeid Teaching Hospital. The medical and socio-demographic 
data of 61 patients who were admitted to the medical wards in the period from 
January 2006 to June 2007 with liver cirrhosis were retrieved and reviewed. 
Results: Out of the 61 patients 38(62%) were males. The age of the patients 
ranged from 17 to 80 years, with mean (± SD) of 49 ± 12.9 years. Alcohol consumption was found 
to be the commonest cause of liver cirrhosis, followed by hepatitis B infection. Hepatitis C infection 
determined as a cause of liver cirrhosis in only one patient. Common complications included ascites 
(92%), hepatic encephalopathy (19%), portal hypertension (8%), hepatocellular carcinoma (5%), 
and spontaneous bacterial peritonitis (3%). In the majority of patients, management was based on 
diuretics (furosemide and spironolactone) and dietary sodium restriction. Few patients received 
albumin infusion before therapeutic ascitic fluid aspiration. Silymarin in combination with 
multivitamins was commonly used in management of our patients. 
Conclusion: Ethanol consumption and HBV infection were the commonest causes of liver cirrhosis 
in our patients. Religious and Health education to abandon ethanol intake and prohibit traditional 
practices that could predispose individuals to hepatitis B infection should be emphasized. Universal 
immunization with hepatitis B vaccine should be commenced to reduce the incidence of HBV-
related chronic liver diseases.  
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irrhosis of the liver is a histological 
diagnosis based on three essential 
criteria: diffuse disease, presence of 
fibrosis, and replacement of normal 
architecture by abnormal nodules1.  
Whereas in Europe and North America high 
alcohol consumption is a very frequent cause 
of cirrhosis of the liver, in many Asian and 
Africans countries hepatitis B virus is the 
most important etiologic agent2. 
Ascites is the most common complication of 
liver cirrhosis3. 
Bacterial infections, portal hypertension, 
hepatorenal syndrome, portopulmonary 
hypertension, hepatopulmonary hypertension,  
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 hepatic hydrothorax, hepatocellular 
carcinoma (HCC) as well as alterations in 
cerebral blood flow are well described 
complications of cirrhosis4-7. 
        Restriction of sodium intake and 
enhancing sodium excretion by diuretics is 
the mainstay of the treatment of ascites8. 
Treating cirrhotic patients with oesophageal 
varices with propranolol significantly reduces 
the incidence of first variceal bleeding9. 
Prophylaxis with norfloxacin 400 mg daily 
significantly reduces the incidence of 
spontaneous bacterial peritonitis in high-risk 
cirrhotic patients10. 
        Elobeid Teaching Hospital in Kordofan 
state, Middle West of Sudan has a wide catch 
up area including different states (North 
Kordofan, West Kordofan, South Kordofan, 
parts of Darfour states). Most of the 
inhabitants work in agriculture, shepherds, 
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and manual workers; hence most of the 
inhabitants are of low socio-economic classes. 
  
Patients and methods: 
          This study is a hospital based study. It 
was carried out in Elobeid Teaching Hospital. 
The medical and socio-demographic data of 
61 patients who were admitted to the medical 
wards in the period from January 2006 to 
June 2007 with liver cirrhosis were retrieved 
from the hospital records, reviewed and 
analyzed. 
Results: 
        Out of 61 patients 38(62%) were males. 
The ages of the patients ranged from 17 to 80 
years, with a mean (± SD) of 49 ± 12.9 years 
(Fig.1) 
 




57(92%) patients came from rural areas. 
24(39%) patients have repeated hospital 
admissions with liver cirrhosis. Two patients 
received blood transfusion following bleeding  
from oesophageal varices. One patient 
received blood transfusion following 
haemorrhage due to snake bite and this is the 
only patient in whom screening for hepatitis C 
antibodies was positive. 14(23%) patients 
used to drink alcohol for average of 16.5 
years. 17(27%) patients gave past history of 
jaundice and two of them are alcoholics. 
Screening for HBsAg in 23 patients was 
positive in 13 (56.5%). 
           Clinical examination revealed jaundice 
in 17(27%), anaemia in12 (19%), shrunken 
liver in 34(56%), hepatomegaly 12(19%), 
splenomegaly 20 (40%), and ascites in 55 
(92%) patients. The mean (± SD) of systolic 
blood pressure was 117 ± 12.5 mmHg, while 
mean (± SD) of diastolic blood pressure was 
72 ± 7.8 mmHg. 
         Ultrasound examination of the abdomen 
showed shrunken liver in 34 (56%), normal 
size of liver with increased echogenicity in 5 
(8%), hepatomegaly with increased 
echogenicity in 17 (28%) and enlarged 
nodular liver in 5 (8%) patients. Massive 
ascites was demonstrated in 44 (72%) 
patients, while in 17 (28%) patients the 
ultrasound reports showed mild to moderate 
ascites. 
        The mean serum albumin (± SD) was 2.9 
± 0.44 mg/dl. The mean ascitic fluid albumin 
(± SD) was 2 ± 1.6 mg/dl. Serum-ascitic fluid 
albumin gradient (SAAG) was calculated in 
16 patient and the result is shown in table (1). 








Drugs used in of cirrhotic ascites include 
spironolactone (85%) and furosemide (75%). 
Silymarin was prescribed for 35(57%) 
cirrhotic patients. Oral lactulose was given for 
patients with hepatic encephalopathy. 
No Serum albumin 
      (mg/dl) 
Ascitic fluid 
albumin 
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           The main age (± SD) of the patients 
was 49 ± 12.9 years and there was male 
preponderance with male: female ratio of 
1.7:1. These findings are in line with some 
Nigerian reports11. 
        Unfortunately, similar to literature from 
West Africa12, most of the patients came late 
with very advanced decompensated liver 
cirrhosis. Local alcohol consumption and 
chronic hepatitis B infection seem to be the 
main causes of liver cirrhosis in this series. 
This fact differs from reports from European 
and Asian countries where alcohol 
consumption and hepatitis C infection 
dominate13. HBV infection was found to be 
the commonest cause of liver cirrhosis in 
some African countries like Nigeria14. 
       In only one patient the liver cirrhosis was 
due to hepatitis C infection a fact which is 
quite different from reports from Pakistan in 
which hepatitis C is the leading cause of liver 
cirrhosis15. No obvious cause to explain that.  
However, the initial paucity of testing for 
hepatitis C virus might have played an 
important role in our results. 
         In 26(43%) patients the systolic blood 
pressure was at the lower limits of normal 
while the mean diastolic blood pressure was 
72 ± 7.8 mmHg, this is similar to what is 
mentioned in the literature16. 
Splenomegaly was detected in 20(33%) 
patients and this is similar to other reports17 
Ascites was detected in 95% of patients 
ranging from mild to massive ascites as 
mentioned in the literature18 
        In the majority of patents in whom the 
Serum Ascitic fluid Albumin Gradient 
(SAAG) was calculated Table (1), it was 
greater than 1.1 g/dl supporting the 
assumption that the ascites in these patients is 
due to liver cirrhosis19. 
The incidence of HCC in patients with liver 
cirrhosis is estimated to be 3 to 5% per year20 
Only three patients of those included in our 
study proved to have HCC (Fig.2). The low 
incidence may be due to lack of facilities for 
the diagnosis of early stages of the tumour. 
Missing the correct diagnosis may explain the 
low existence (3%) of Spontaneous Bacterial 
Peritonitis (SBP) in our patients when  
 
compared with the 7-23% reported 
elsewhere21.  
        One patient was found to have right-
sided pleural effusion (hepatic hydrothorax). 
This complication seems to be a relatively 
uncommon, although in some references the 
estimated prevalence is 5-12% in patients 
with cirrhosis of the liver22. Similar to reports, 
portal hypertension is evident in all patients 
with liver cirrhosis on abdominal ultrasound 
examination25. The rate of variceal bleeding is 
approximately 10-30% per year23. Only one 
of our patients had bleeding due to varices.  
Although hepatic encephalopathy represents a 
potentially reversible decrease24, nine of the 
twelve patients (19%) who presented with 
encephalopathy (Fig. 2) died in spite of 
supportive measures  
Conclusion: Alcohol and hepatitis B 
infection are the main causes of liver cirrhosis 
in our patients, therefore, health education to 
prohibit traditional practices that could 
predispose individuals to hepatitis B infection 
should be emphasized. Universal 
immunization with hepatitis B vaccine should 
be commenced to reduce the incidence of 
HBV-related chronic liver diseases. Alcohol 
intake problem should be handled by the local 
health advisors and religious leaders. 
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